News

Medivir CEO Maris Hartmanis said: "The recommendation is one additional step in the global strategy that our partner Janssen has for simeprevir, to offer a new and efficacious

According to the recommendation, Bexsero should be routinely used in infants from two months of age to help protect against meningococcal serogroup B (meningitis B). The implementation will

NCCN ORP vice president Dr Diane E. Paul noted it is grateful to collaborate with Boehringer Ingelheim on this ground-breaking research initiative. "The research supported by this grant

The patent (No. 8,663,987) covers BrainStorm’s proprietary stem cells induced to secrete elevated levels of neurotrophic factors for the treatment of neurodegenerative diseases. The neurotrophic factors secreted by

The drug is indicated for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn’s disease (CD) who

The results showed that the trial did not meet its first or second co-primary endpoint as it did not significantly extend disease-free survival (DFS) when compared to placebo

In January 2014, the company filed its NDA with the FDA for the treatment of malignant hyperthermia, a condition that can be triggered when genetically susceptible individuals come

TPI 287 is a new taxoid derivative, called as an abeotaxane, which binds to and stabilizes the assembly of microtubules similarly to commonly used taxanes, including paclitaxel (Taxol

In October 2013, the company has received approval from the European authorities for Lucentis PFS, which is a new way of administering Lucentis that is specifically designed for